• 2023年
• 2022年
• 2021年
• 2020年
• 2019年
• 2018年
• 2017年
• 2016年
• 2015年

2022年

1. Koyasu N, Hyodo F, Iwasaki R, Eto H, Elhelaly AE, Tomita H, Shoda S, Takasu M, Mori T, Murata M, Hara A, Noda Y, Kato H, Matsuo M Spatiotemporal imaging of redox status using in vivo dynamic nuclear polarization magnetic resonance imaging system for early monitoring of response to radiation treatment of tumor. Free Radic Biol Med. 2022;179:170-180.
2. Suto T, Kato H, Kawaguchi M, Matsuo M, Takiwaki M, Ogawa T Reticular enhancement of the submandibular gland on contrast-enhanced magnetic resonance imaging in three cases with IgG4-related chronic sclerosing sialadenitis. Neuroradiol J. 2022;35(2):243-246.
3. Kawaguchi M, Kato H, Matsuyama K, Noda Y, Hyodo F, Matsuo M Prognostic value of ¹⁸F-FDG PET/CT and MRI features in patients with high-risk and very-high-risk cutaneous squamous cell carcinoma. Br J Radiol. 2022;95(1132):20211003.
4. Kawaguchi M, Kato H, Miyazaki M, Nagano A, Matsuo M Imaging Findings of Calcaneal Cyst and Lipoma: Can Intraosseous Cyst Change Into Lipoma With Advancing Age? J Comput Assist Tomogr. 2022;46(3):434-439.
5. Kuroki M, Shibata H, Kuze B, Ohashi T, Kohyama K, Kato H, Kato H, Miyazaki T, Tomita H, Ogawa T Genetic Panel Test of Double Cancer of Signet-Ring Cell/Histiocytoid Carcinoma of the Eyelid and Papillary Thyroid Carcinoma: Case Report and Literature Review. Cureus. 2022;14(5):e25192.
6. Mori T, Kato H, Kawaguchi M, Hatano Y, Ishihara T, Noda Y, Hyodo F, Matsuo M, Furui T, Morishige KI A comparative analysis of MRI findings in endometrial cancer: differentiation between endometrioid adenocarcinoma, serous carcinoma, and clear cell carcinoma. Eur Radiol. 2022;32(6):4128-4136.
7. Suto T, Kato H, Kawaguchi M, Kobayashi K, Miyazaki T, Ando T, Noda Y, Hyodo F, Matsuo M, Ishihara H, Ogawa T MRI findings of epithelial-myoepithelial carcinoma of the parotid gland with radiologic-pathologic correlation. Jpn J Radiol. 2022;40(6):578-585.
8. Kaga T, Noda Y, Mori T, Kawai N, Miyoshi T, Hyodo F, Kato H, Matsuo M Unenhanced abdominal low-dose CT reconstructed with deep learning-based image reconstruction: image quality and anatomical structure depiction. Jpn J Radiol. 2022;40(7):703-711.
9. Ota M, Hyodo F, Matsuo S, Kato T, Kawai N, Nakamura F, Fujimoto K, Kaneko Y, Kato H, Matsuo M Investigation of the Clinical Efficacy of ⁹⁹ᵐTc-Sestamibi Washout in Patients with Acute Myocardial Infarction and Comparison with Stress Myocardial Imaging with ⁹⁹ᵐTc-Sestamibi Using a Two-Day Protocol. Iran J Radiol. 2022;19(2):e122423.
10. Kawaguchi M, Kato H, Kobayashi K, Miyazaki T, Nagano A, Noda Y, Hyodo F, Matsuo M MRI findings to differentiate musculoskeletal dedifferentiated liposarcoma from atypical lipomatous tumor. Radiol Med. 2022;127(12):1383-1389.
11. Uno A, Yamamoto S, Iihara H, Fujii H, Makita C, Hayasaki Y, Ueda Y, Ito M, Takenaka M, Kumano T, Mori M, Yasue M, Kato-Hayashi H, Kobayashi R, Morishige KI, Matsuo M, Hayashi H, Suzuki A Control and Risk Factors of Nausea and Vomiting in Patients With Cervical Cancer Receiving Radiotherapy. Anticancer Res. 2022;42(6):3117-3123.
12. Taniguchi T, Tinuma K, Nakano M, Kawase M, Takeuchi S, Kato D, Takai M, Nakane K, Tshihara T, Ito M, Kumano T, Matsuo M, Koie T Chronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOAR® system. Prostate Int. 2022;10(4):207-212.
13. Takeuchi S, Tinuma K, Nakano M, Kawase M, Kato D, Kawase K, Takai M, Nakane K, Ito M, Kumano T, Matsuo M, Koie T Patient age as a predictive factor in biochemical recurrence following brachytherapy: Oncological outcomes at a single center. Prostate Int. 2022;10(4):224-228.
14. Tomita N, Tsuchiyama H, Makita C, Ohshima Y, Nagai A, Baba F, Kuno M, Otsuka S, Kondo T, Sugie C, Kawai T, Takaoka T, Okazaki D, Torii A, Niwa M, Kita N, Takano S, Kawakami S, Matsuo M, Kumano T, Ito M, Adachi S, Abe S, Murao T, Hiwatashi A Daily irradiation versus irradiation at two-to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial. BMC Cancer. 2022;22(1):1259.
15. Kawaguchi M, Kato H, Noda Y, Furui T, Morishige KT, Hyodo F, Matsuo M Uterine extension determined by MRI: a useful parameter for differentiating subserosal leiomyomas from ovarian tumors. Abdom Radiol (NY). 2022;47(3):1142-1149.
16. Kawai T, Matsuo M, Takakusagi Y, Saito K, Hyodo F, Devasahayam N, Matsumoto S, Kishimoto S, Yasui H, Yamamoto K, Krishna MC Continuous monitoring of postirradiation reoxygenation and cycling hypoxia using electron paramagnetic resonance imaging. NMR Biomed. 2022;35(10):e4783.
17. Mizuta Y, Akahoshi T, Eto H, Hyodo F, Murata M, Tokuda K, Eto M, Yamaura K Noninvasive Diagnosis of the Mitochondrial Function of Doxorubicin-Induced Cardiomyopathy Using In Vivo Dynamic Nuclear Polarization-Magnetic Resonance Imaging. Antioxidants (Basel). 2022;11(8):1454.
18. Kawada H, Shoda S, Miyoshi T, Takasu M, Tanahashi Y, Iwasaki R, Nagata S, Kawai N, Noda Y, Goshima S, Hyodo F, Mori T, Matsuo M Radiological arterial anatomy in mature microminipigs as a pre-clinical research model in interventional radiology. Cardiovasc Intervent Radiol. 2022;45(5):705-708.
19. Noda Y, Kawai N, Nagata S, Nakamura F, Mori T, Miyoshi T, Suzuki R, Kitahara F, Kato H, Hyodo F, Matsuo M Deep learning image reconstruction algorithm for pancreatic protocol dual-energy computed tomography: image quality and quantification of iodine concentration. Eur Radiol. 2022;32(1):384-394.
20. Noda Y, Pisuchpen N, Mercaldo ND, Sekigami Y, Michelakos T, Parakh A, Wo JY, Qadan M, Ferrone C, Lillemoe KD, Ryan DP, Clark JW, Fernandez-Del Castillo C, Hong TS, Kambadakone AR Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapy. Eur Radiol. 2022;32(4):2470-2480.
21. Noda Y, Nakamura F, Kawamura T, Kawai N, Kaga T, Miyoshi T, Kato H, Hyodo F, Matsuo M Deep-learning image-reconstruction algorithm for dual-energy CT angiography with reduced iodine dose: preliminary results. Clin Radiol. 2022;77(2):e138-e146.
22. Noda Y, Tomita H, Ishihara T, Tsuboi Y, Kawai N, Kawaguchi M, Kaga T, Hyodo F, Hara A, Kambadakone AR, Matsuo M Prediction of overall survival in patients with pancreatic ductal adenocarcinoma: histogram analysis of ADC value and correlation with pathological intratumoral necrosis. BMC Med Imaging. 2022;22(1):23.
23. Noda Y, Kawai N, Kawamura T, Kobori A, Miyase R, Iwashima K, Kaga T, Miyoshi T, Hyodo F, Kato H, Matsuo M Radiation and iodine dose reduced thoraco-abdomino-pelvic dual-energy CT at 40 keV reconstructed with deep learning image reconstruction. Br J Radiol. 2022;95(1134):20211163.
24. Noda Y, Kawai N, Kaga T, Ishihara T, Hyodo F, Kato H, Kambadakone AR, Matsuo M Vascular involvement and resectability of pancreatic ductal adenocarcinoma on contrast-enhanced MRI: comparison with pancreatic protocol CT. Abdom Radiol (NY). 2022;47(8):2835-2844.
25. Ando T, Kato H, Matsuo M Different CT imaging findings between histological subtypes in patients with primary thyroid lymphoma. Radiol Med. 2022;127(2):191-198.
26. Mizutani C, Matsuhashi N, Tomita H, Takahashi T, Suetsugu T, Tajima JY, Kiyama S, Yasufuku I, Tanaka Y, Okumura N, Murase K, Futamura M, Kawaguchi M, Ishihara T, Matsuo M, Miyazaki T, Hara A, Yoshida K Predictive value of the Prognostic Nutritional Index in neoadjuvant chemoradiotherapy for rectal cancer. Cancer Diagn Progn. 2022;2(1):38-48.
27. Ninomiya H, Ozeki M, Nozawa A, Yasue S, Endo S, Inuzuka M, Obara N, Mochizuki K, Kawaguchi M, Kaneko Y, Ohe N, Aoki Y, Matsuo M, Iwama T, Ohnishi H A rare pediatric case of McCune-Albright syndrome with acute visual disturbance: Case report. Medicine (Baltimore). 2022;101(6):e28815.
28. Tanaka O, Taniguchi T, Adachi K, Nakaya S, Kiryu T, Ukai A, Makita C, Matsuo M Effect of stomach size on organs at risk in pancreatic stereotactic body radiotherapy. Radiat Oncol. 2022;17(1):136.
29. Nakano T, Aoyama H, Onodera S, Igaki H, Matsumoto Y, Kanemoto A, Shimamoto S, Matsuo M, Tanaka H, Oya N, Matsuyama T, Ohta A, Maruyama K, Tanaka T, Kitamura N, Akazawa K, Maebayashi K; Japanese Radiation Oncology Study Group 13-1 (JROSG13-1) Investigators Reduced-dose WBRT combined with SRS for 1-4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control. Clin Transl Radiat Oncol. 2022;37:116-129.